DKSH and Pfizer Expand Collaboration in Thailand

DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, will provide marketing and promotional services for certain Pfizer antibiotic and cardiovascular products in hospitals, clinics and pharmacies across Thailand. 

Pfizer has a leading portfolio of products and medicines that support wellness and prevention as well as treatment and cures for diseases across a broad range of therapeutic areas. Pfizer’s relationship with DKSH in Thailand dates back to 2013. The recently signed agreement between DKSH and Pfizer is a significant expansion in terms of products.

“Working with DKSH allows us to accelerate growth and expand business while focusing on our competencies. With DKSH being in Thailand for 110 years, we trust their in-depth expertise and ability to find new growth opportunities,” said Patrick van der Loo, Global Established Pharma Business Unit Lead and Thailand Country Manager, Pfizer.

“Through this agreement, Pfizer will have access to our dedicated sales and marketing healthcare specialists in Thailand. Pfizer’s ongoing confidence in DKSH confirms our position as partner of choice for companies who seek to grow their business in Thailand and in the region,” said John Clare, Vice President, Business Unit Healthcare, DKSH Thailand.   

This agreement will strengthen DKSH’s market position in Thailand while contributing incrementally to the Group’s overall profitability over time.